Patanjali Scientists' Research on Renogrit Among Top 100 Papers of 2024 in Scientific Reports

Inspired by the vision of Yoga guru Baba Ramdev and driven by evidence-based Ayurvedic research, scientists at Patanjali have achieved a significant milestone as their research paper on the herbal formulation Renogrit has been recognised among the top 100 research papers of 2024 in the prestigious Scientific Reports journal, part of the globally renowned Nature Portfolio publication.

- STATESMAN NEWS SERVICE

With an Impact Factor of 3.8, Scientific Reports ranks as the fifth most-cited journal worldwide. The study on Renogrit has already been downloaded 2,568 times, highlighting the increasing global interest in Ayurvedic medicines as not only effective therapeutic solutions but also as a subject of scientific exploration.

The research underscores how a simple herbal formulation can combat severe diseases without adverse side effects, reinforcing Ayurveda's scientific credibility on an international scale.

Patanjali's Ayurvedic formulation, Renogrit, has demonstrated its potential not only in repairing kidney damage caused by the allopathic anti-cancer drug, cisplatin, but also in alleviating oxidative stress on kidney cells.